Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease.

Documenti analoghi

• Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
  di: Thorsen, S, et al.
  Pubblicazione: (1984)
• Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
  di: Leiper, K, et al.
  Pubblicazione: (1994)
• Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
  di: Zuo, Yu, et al.
  Pubblicazione: (2020)
• Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
  di: Zuo, Yu, et al.
  Pubblicazione: (2021)
• Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease
  di: Ogston, C. M., et al.
  Pubblicazione: (1966)